Epigenomic analysis could lead to early detection and new therapies
Irvine, CA – May 12, 2020 – A team of researchers from the University of California, Irvine and San Diego have been awarded $3.8 million by the National Institute on Aging to conduct an epigenomic analysis of neural circuits in the brain. By revealing molecular changes that occur during the course of Alzheimer’s disease (AD), the team hopes to identify new therapeutic targets and molecular biomarkers for early detection and better treatment.
The interdisciplinary research team is led by multiple principal investigators, including Xiangmin Xu, PhD, a professor of anatomy and neurobiology and director of the Center for Neural Circuit Mapping at the UCI School of Medicine, Carl Cotman, PhD, a professor of neurology and founding director of the Institute for Brain Aging and Dementia at the UCI School of Medicine, and Bing Ren, PhD, a professor of cellular and molecular medicine and director of the Center for Epigenomics at the UCSD School of Medicine.
The team will study how the epigenome of key cell types in neural circuits shapes hippocampal circuit activity and behaviors during AD progression. The proposed research, conducted using mouse models that mimic the neurodegenerative disease, will involve the use of single cell genomic technologies coupled with functional circuit mapping and behavioral analysis.
“Our goal is to reveal the molecular changes that occur during the course of the disease, that impact learning and memory, and identify a path toward early detection and new drug therapies for Alzheimer’s disease,” said Xu.
Alzheimer’s disease is the most common cause of progressive dementia (memory and cognitive loss) in older adults and a growing major health concern in the U.S. Currently, more than 5.5 million Americans may have dementia caused by AD.
“Currently, there is no cure for Alzheimer’s disease,” said Xu. “And, as millions of people are affected by this debilitating condition, it is increasingly critical that we develop better early diagnostic tools and new treatment strategies to care for them.”
URL: https://www.som.uci.edu/news_releases/Xu-awarded-NIA-grant-to-study-Alheimers.asp